Both Semaglutide and copyright represent a class of drugs called Glucagon-like Peptide-1 GLP-1 agonists . These powerful treatments work by mimicking the body's own chemical , Glucagon-like Peptide-1, to support lower blood sugar and stimulate weight reduction . This similar mechanism of function

Individuals struggling with obesity are often faced with limited and sometimes ineffective treatment options. However, a groundbreaking new medication, Semaglutide, is rapidly changing the landscape of weight loss. Approved by regulatory bodies for chronic weight management, Semaglutide acts as